New Edge Advisors, LLC Beyond Air, Inc. Transaction History

New Edge Advisors, LLC

$13.5 Billion
Q2 2024

A detailed history of New Edge Advisors, LLC transactions in Beyond Air, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 75,107 shares of XAIR stock, worth $42,810. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,107

Previous 77,242 2.76%

Holding current value

$42,810

Previous $134,000 70.15%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$0.54 - $1.67 $1,152 - $3,565	-2,135 Reduced 2.76%	75,107 $40,000
Q1 2024 May 14, 2024	SELL	$1.3 - $2.15 $729 - $1,206	-561 Reduced 0.72%	77,242 $134,000
Q4 2023 Feb 13, 2024	SELL	$1.4 - $2.46 $152 - $268	-109 Reduced 0.14%	77,803 $152,000
Q3 2023 Nov 14, 2023	SELL	$2.31 - $4.18 $753 - $1,362	-326 Reduced 0.42%	77,912 $179,000
Q2 2023 Aug 14, 2023	SELL	$4.26 - $6.92 $5,866 - $9,528	-1,377 Reduced 1.73%	78,238 $333,000
Q1 2023 May 12, 2023	SELL	$5.65 - $7.56 $10,170 - $13,608	-1,800 Reduced 2.21%	79,615 $537,000
Q4 2022 Feb 14, 2023	SELL	$5.47 - $7.9 $17,389 - $25,114	-3,179 Reduced 3.76%	81,415 $528,000
Q3 2022 Nov 14, 2022	BUY	$7.42 - $11.39 $19,885 - $30,525	2,680 Added 3.27%	84,594 $629,000
Q2 2022 Aug 09, 2022	SELL	$4.96 - $7.83 $10,778 - $17,014	-2,173 Reduced 2.58%	81,914 $548,000
Q1 2022 May 13, 2022	SELL	$6.33 - $9.53 $25,788 - $38,825	-4,074 Reduced 4.62%	84,087 $562,000
Q4 2021 Feb 17, 2022	SELL	$8.44 - $15.61 $402,613 - $744,643	-47,703 Reduced 35.11%	88,161 $832,000
Q3 2021 Oct 29, 2021	SELL	$5.9 - $12.54 $477 - $1,015	-81 Reduced 0.06%	135,864 $1.51 Million
Q2 2021 Jul 22, 2021	BUY	$4.72 - $7.15 $641,660 - $972,006	135,945 New	135,945 $881,000

Others Institutions Holding XAIR

# of Institutions

Shares Held

11.1M

Call Options Held

54.4K

Put Options Held

View Full List

About Beyond Air, Inc.

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $17M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

More about XAIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Beyond Air, Inc. Transaction History